Početna › Multipli mijelom › Wisconsin
Kliničke studije za Multipli mijelom u državi Wisconsin
28 studija za Multipli mijelom traži sudionike na lokacijama u državi Wisconsin.
Gradovi u državi Wisconsin
Službeni tekst studije (engleski)
Understanding the Mechanisms of Clonal and Non-clonal Cytopenia Following CAR-T Therapy for Multiple Myeloma or CD19+ Lymphoproliferative Disorder (LPD)
- Mayo Clinic Health System-Eau Claire Clinic, Eau Claire
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06630104A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Research Site, Madison
- Research Site, Milwaukee
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07391657A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- University of Wisconsin Carbone Cancer Center, Madison
- Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT04973605A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Medical College Of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07258511A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Froedtert Memorial, Milwaukee
U tijeku regrutacijaFaza 4
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05201781A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple Myeloma
- The Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07116616TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Aurora Cancer Care - Burlington, Burlington
- Aurora Health Care - Germantown Health Center, Germantown
- Aurora Cancer Care - Grafton, Grafton
- i još 13
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT02693535Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT07648264A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
- Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 15. ruj 2026. · NCT06615479Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT06297226Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma
- University of Wisconsin, Madison
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT07479979A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
- Research Site, Milwaukee
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 27. kol 2026. · NCT07681596MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center-University Hospital, Madison
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. kol 2026. · NCT06152575Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- ThedaCare Regional Cancer Center, Appleton
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield
- i još 47
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 19. kol 2026. · NCT04566328Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Gundersen Lutheran, La Crosse
U tijeku regrutacijaFaza 3
Od 18 do 79 godina · Oba spola · Ažurirano 17. kol 2026. · NCT07285239AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
- Research Site, Milwaukee
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT05850234Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
- Froedtert & the Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 1
Od 18 do 80 godina · Oba spola · Ažurirano 10. kol 2026. · NCT05976555A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
- University of Wisconsin - Carbone Cancer Center, Madison
- MCW-Clinical Cancer Center at Froedtert Hospital Campus, Milwaukee
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 6. kol 2026. · NCT07284758Moving Forward With Myeloma: A Lifestyle Intervention for Individuals With Multiple Myeloma
- Medical College of Wisconsin, Milwaukee
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT07236502Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Langlade Hospital and Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- Duluth Clinic Ashland, Ashland
- i još 22
U tijeku regrutacijaFaza 3
Sve dobne skupine · Oba spola · Ažurirano 10. lip 2026. · NCT05561387Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- St Vincent HSHS (Green Bay Oncology), Green Bay
- University of Wisconsin Hospital and Clinics, Madison
- Froedtert Memorial Lutheran Hospital, Milwaukee
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 4. lip 2026. · NCT05243797Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
- University of Wisconsin Clinical Science Center, Madison
- Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 2
Od 19 godina i više · Oba spola · Ažurirano 4. lip 2026. · NCT06974786Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 1. tra 2026. · NCT05862012Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 28. sij 2026. · NCT04240054Cilta-Talq Fusion Study: A Phase 1b Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients With Relapsed/Refractory Multiple Myeloma
- Froedtert & the Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 5. sij 2026. · NCT07093554Long-term Follow-up Study of Patients Receiving CAR-T Cells
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaOpažajna studija
Od 18 do 80 godina · Oba spola · Ažurirano 10. stu 2025. · NCT03375619CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
- Froedtert and the Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2025. · NCT05722418Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.